Marshall & Sterling Wealth Advisors’s DexCom DXCM Stock Holding History

Marshall & Sterling Wealth Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-63	Closed	-$4.24K	–	426
2025 Q3	$4.24K	Hold	63	–	–	﹤0.01%	522
2025 Q2	$5.5K	Hold	63	–	–	﹤0.01%	470
2025 Q1	$4.3K	Buy	+63	New	+$5.14K	﹤0.01%	493

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marshall & Sterling Wealth Advisors's DXCM Position: Q4 2025 in Review

Marshall & Sterling Wealth Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 63 shares — an estimated $4.24K sold.

Marshall & Sterling Wealth Advisors first reported a position in DXCM in Q1 2025 and held it in 3 quarters. The position peaked at $5.5K in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Marshall & Sterling Wealth Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Marshall & Sterling Wealth Advisors sold 63 DexCom shares in Q4 2025, an estimated $4.24K.
Marshall & Sterling Wealth Advisors first reported a position in DexCom in Q1 2025 and held it in 3 quarters.
Marshall & Sterling Wealth Advisors's DexCom position peaked at $5.5K in Q2 2025.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.